RIPK3 and colitis: Moreover, pharmacological inhibition of RIPK3 substantially alleviated experimental colitis with reduced inflammation in Gab1IEC -KO mice, suggesting that hyperactivation of RIPK3 and necroptosis largely contributes to exacerbated colitis in epithelial Gab1-deficient mice.